Fresenius Kabi España Revenue and Competitors
Estimated Revenue & Valuation
- Fresenius Kabi España's estimated annual revenue is currently $32.4M per year.
- Fresenius Kabi España's estimated revenue per employee is $201,000
Employee Data
- Fresenius Kabi España has 161 Employees.
- Fresenius Kabi España grew their employee count by 11% last year.
Fresenius Kabi España's People
Name | Title | Email/Phone |
---|---|---|
1 | Director de aseguramiento de la calidad | Reveal Email/Phone |
2 | Medical Manager Enteral Nutrition | Reveal Email/Phone |
3 | Supply Chain Manager | Reveal Email/Phone |
4 | Social Media Manager | Reveal Email/Phone |
5 | Indirect Procurement Manager | Reveal Email/Phone |
6 | Supply Chain Manager | Reveal Email/Phone |
7 | Marketing Manager | Reveal Email/Phone |
8 | IT Manager | Reveal Email/Phone |
9 | Delegada comercial en Nutrición Enteral | Reveal Email/Phone |
10 | Product Specialist | Reveal Email/Phone |
Fresenius Kabi España Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $19.7M | 98 | 5% | N/A | N/A |
#2 | $19.7M | 98 | 42% | N/A | N/A |
#3 | $10.5M | 52 | -17% | N/A | N/A |
#4 | $32.4M | 161 | 11% | N/A | N/A |
#5 | $49M | 244 | 6% | N/A | N/A |
#6 | $7.2M | 36 | N/A | N/A | N/A |
#7 | $36.8M | 183 | 9% | N/A | N/A |
#8 | $44.8M | 223 | 13% | N/A | N/A |
#9 | $147.9M | 736 | 10% | N/A | N/A |
#10 | $29.3M | 146 | -5% | N/A | N/A |
What Is Fresenius Kabi España?
Fresenius Kabi es una empresa global de salud especializada en medicamentos vitales y tecnologÃas para la infusión, transfusión y nutrición clÃnica. Nuestros productos y servicios sirven para el cuidado de los pacientes crÃticos y crónicos.
keywords:N/AN/A
Total Funding
161
Number of Employees
$32.4M
Revenue (est)
11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $47.8M | 161 | 5% | N/A |
#2 | $21.4M | 162 | 6% | N/A |
#3 | N/A | 163 | 9% | N/A |
#4 | $27.1M | 164 | 2% | N/A |
#5 | N/A | 165 | 34% | N/A |